Honar Cherif

2.1k total citations · 1 hit paper
58 papers, 1.4k citations indexed

About

Honar Cherif is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Honar Cherif has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 21 papers in Oncology and 15 papers in Genetics. Recurrent topics in Honar Cherif's work include Neutropenia and Cancer Infections (10 papers), Multiple Myeloma Research and Treatments (9 papers) and Platelet Disorders and Treatments (9 papers). Honar Cherif is often cited by papers focused on Neutropenia and Cancer Infections (10 papers), Multiple Myeloma Research and Treatments (9 papers) and Platelet Disorders and Treatments (9 papers). Honar Cherif collaborates with scholars based in Sweden, Qatar and United States. Honar Cherif's co-authors include Magnus Björkholm, Mats Kalin, Martin Steinhoff, Maysaloun Merhi, S Mestiri, Majid Alam, Said Dermime, Karama Makni‐Maalej, Varghese Inchakalody and Shahab Uddin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Honar Cherif

50 papers receiving 1.4k citations

Hit Papers

CAR-cell therapy in the era of solid tumor treatment: cur... 2023 2026 2024 2025 2023 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances
    2023 373 citations Honar Cherif et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Honar Cherif Sweden 17 778 313 310 242 194 58 1.4k
Solveig G. Ericson United States 20 883 1.1× 227 0.7× 182 0.6× 284 1.2× 118 0.6× 67 1.4k
Holger W. Auner United Kingdom 24 619 0.8× 677 2.2× 126 0.4× 566 2.3× 285 1.5× 87 1.7k
T. de Witte Netherlands 23 394 0.5× 254 0.8× 335 1.1× 875 3.6× 148 0.8× 54 1.4k
Esa Jantunen Finland 27 796 1.0× 215 0.7× 309 1.0× 839 3.5× 166 0.9× 114 2.1k
Tanya Trippett United States 24 655 0.8× 580 1.9× 197 0.6× 380 1.6× 145 0.7× 79 1.9k
Marcel P. Devetten United States 20 263 0.3× 433 1.4× 288 0.9× 704 2.9× 91 0.5× 45 1.5k
Válerie de Haas Netherlands 28 428 0.6× 868 2.8× 230 0.7× 1.4k 5.9× 90 0.5× 99 2.5k
Erden Atilla Türkiye 14 505 0.6× 183 0.6× 200 0.6× 289 1.2× 144 0.7× 61 876
Renée M. Y. Barge Netherlands 23 343 0.4× 379 1.2× 318 1.0× 504 2.1× 197 1.0× 44 1.5k
Xianmin Song China 17 317 0.4× 368 1.2× 179 0.6× 364 1.5× 69 0.4× 69 953

Countries citing papers authored by Honar Cherif

Since Specialization
Citations

This map shows the geographic impact of Honar Cherif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honar Cherif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honar Cherif more than expected).

Fields of papers citing papers by Honar Cherif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honar Cherif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honar Cherif. The network helps show where Honar Cherif may publish in the future.

Co-authorship network of co-authors of Honar Cherif

This figure shows the co-authorship network connecting the top 25 collaborators of Honar Cherif. A scholar is included among the top collaborators of Honar Cherif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honar Cherif. Honar Cherif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Omri, Halima El, et al.. (2024). Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review. Frontiers in Oncology. 14. 1390747–1390747. 1 indexed citations
4.
Cherif, Honar, Qian Cai, Concetta Crivera, et al.. (2024). Overall Survival and Treatment Patterns Among Patients With Warm Autoimmune Hemolytic Anemia in Sweden: A Nationwide Population‐based Study. European Journal Of Haematology. 114(1). 129–138.
5.
Ljungman, Per, Adjmal Nahimi, Arta Dreimane, et al.. (2023). Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study. Journal of Neurology Neurosurgery & Psychiatry. 95(2). 125–133. 16 indexed citations
6.
Kjellander, Christian, E Hernlund, M Ivergård, et al.. (2023). Economic burden of sickle cell disease in Sweden: a population-based national register study with 13 years follow up. DiVA at Umeå University (Umeå University). 2.
7.
Mohamed, Shehab, et al.. (2023). Recurrent sideroblastic anemia during pregnancy. SHILAP Revista de lepidopterología. 11(1). e6814–e6814. 2 indexed citations
8.
Alfraih, Feras, Ahmad Alhuraiji, Murtadha Al‐Khabori, et al.. (2023). Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working Group. Cancer Reports. 7(2). e1931–e1931.
9.
Alshemmari, Salem, et al.. (2023). Evidence-Based Management of Chronic Lymphocytic Leukemia: Consensus Statements from the Gulf Region. Acta Haematologica. 147(3). 260–279. 1 indexed citations
10.
11.
Larsson, Anders, et al.. (2023). CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 10(5). 4 indexed citations
12.
Cherif, Honar, et al.. (2023). Differentiation syndrome in patients with acute promyelocytic leukemia. SHILAP Revista de lepidopterología. 11(1). e6697–e6697. 1 indexed citations
13.
Wahlin, Björn E., et al.. (2022). Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study. Upsala Journal of Medical Sciences. 127. 3 indexed citations
14.
Einarsdottir, Sigrun, Anne‐Marie Landtblom, Lenka Novakova, et al.. (2020). Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing–remitting multiple sclerosis: an observational study. Journal of Neurology Neurosurgery & Psychiatry. 92(2). 189–194. 31 indexed citations
15.
Ekstrand, Charlotta, Shahram Bahmanyar, Honar Cherif, Helle Kieler, & Marie Linder. (2020). Cancer risk in patients with primary immune thrombocytopenia – A Swedish nationwide register study. Cancer Epidemiology. 69. 101806–101806. 7 indexed citations
16.
17.
Karlsson, Torbjörn & Honar Cherif. (2016). Effect of Intravenous Iron Supplementation on Iron Stores in Non-Anemic Iron-Deficient Patients with Hereditary Hemorrhagic Telangiectasia. Hematology Reports. 8(1). 6348–6348. 2 indexed citations
18.
Ekstrand, Charlotta, Marie Linder, Honar Cherif, Helle Kieler, & Shahram Bahmanyar. (2016). Increased susceptibility to infections before the diagnosis of immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 14(4). 807–814. 20 indexed citations
19.
Cherif, Honar & Torbjörn Karlsson. (2014). Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia. Upsala Journal of Medical Sciences. 119(4). 350–353. 3 indexed citations
20.
Cherif, Honar, Ola Landgren, Helle Bossen Konradsen, Mats Kalin, & Magnus Björkholm. (2005). Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases. Vaccine. 24(1). 75–81. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Solveig G. Ericson Breakdown of academic impact, for papers by Holger W. Auner Breakdown of academic impact, for papers by T. de Witte Breakdown of academic impact, for papers by Esa Jantunen Breakdown of academic impact, for papers by Tanya Trippett Breakdown of academic impact, for papers by Marcel P. Devetten Breakdown of academic impact, for papers by Válerie de Haas Breakdown of academic impact, for papers by Erden Atilla Breakdown of academic impact, for papers by Renée M. Y. Barge Breakdown of academic impact, for papers by Xianmin Song
Rankless by CCL
2026